International Journal of Pediatrics

The Fetus as a Cardiac Patient: Assessment and Therapy of Cardiovascular Pathology before Birth


Publishing date
15 Sep 2010
Status
Published
Submission deadline
15 Mar 2010

1Fetal Cardiovascular Program, University of California San Francisco, 505 Parnassus Avenue Box 0214, San Francisco, CA 94143, USA

2Department of Cardiology, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA

3Department of High Risk Obstetrics and Fetal Medicine, Royal Prince Alfred Hospital, Missenden Road, Camperdown Sydney, NSW 2050, Australia

4Pediatric Surgery and Fetal Treatment Center, University of California San Francisco, 513 Parnassus Avenue Box 0570, San Francisco, CA 94143, USA

5Fetal Cardiac Unit and Department of Pediatrics, Monash University, Clayton 3168, Melbourne, VIC, Australia


The Fetus as a Cardiac Patient: Assessment and Therapy of Cardiovascular Pathology before Birth

Description

The past few decades have seen major advances in evaluation and treatment of fetal cardiovascular diseases. Recognition of structural pathology in the developing human heart can now be seen by ultrasound as early as the 12th week of pregnancy. Detailed assessment of cardiac rhythm, function, and myocardial mechanics is now possible. Several centers now incorporate fetal cardiovascular assessment routinely in the evaluation of diseases such as CCAM, TTTS, and CDH in which structural heart disease may impose significant comorbidity postnatally while functional pathology secondary to the primary process may impact the fetus in utero. Recognition of treatable fetal cardiac disease may be altering the prognosis for these patients in the perinatal period, as in utero treatment of the primary disease may improve the hemodynamic derangements. Regardless of training and background, healthcare professionals involved in the diagnosis and management of diseases of the fetus and newborn need to be cognizant of the potential contribution of prenatal cardiac assessment and treatment in the congenitally malformed or unwell fetus.

We invite authors to present original research or review articles that will add to the growing body of literature on the assessment of the cardiovascular system in the fetus and prenatal/perinatal therapy for cardiovascular pathology in this unique group of patients.

Potential topics include, but are not limited to:

  • Prenatal detection of structural or functional heart disease and impact on outcomes and natural history of disease
  • Fetal intervention for structural, functional, or rhythm pathology
  • Role of fetal cardiac assessment in evaluation and treatment of noncardiac diseases of the fetus
  • Prenatal/perinatal assessment of other organ systems at risk for injury in the presence of cardiovascular pathology
  • Choices during the perinatal period: impact of prenatal diagnosis, cost analysis, addressing nonaggressive management after birth

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijped/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.shindawi.com/ according to the following timetable:

International Journal of Pediatrics
 Journal metrics
Acceptance rate23%
Submission to final decision98 days
Acceptance to publication27 days
CiteScore-
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.